@article{1e8059b688a640fcbb22a095cfbf979c,
title = "Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview",
abstract = "In recent years, Botulinum Toxin has been shown to be efficacious and safe in the treatment of sialorrhea, but scanty data are available on its long term use. The aim of this study was to investigate adverse events, discriminate differences in safety, and evaluate the efficacy of long-term use of both abobotulinumtoxinA and rimabotulinumtoxinB ultrasound-guided injections for sialorrhea in a retrospective trial. Moreover we review the literature on this topic.",
keywords = "Adverse effects, Amyotrophic Lateral Sclerosis, Botulinum Toxin, Long-term treatment, Parkinson's Disease, Sialorrhea, Adverse effects, Amyotrophic Lateral Sclerosis, Botulinum Toxin, Long-term treatment, Parkinson's Disease, Sialorrhea",
author = "{Di Stasio}, Enrico and Bentivoglio, {Anna Rita} and Martina Petracca and Arianna Guidubaldi and Tamara Ialongo and {Del Grande}, Alessandra and Delia Mulas",
year = "2015",
doi = "10.1016/j.toxicon.2015.08.014",
language = "English",
volume = "107",
pages = "129--140",
journal = "Toxicon",
issn = "0041-0101",
publisher = "Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: asianfo@elsevier.com, tcb@elsevier.co.UK, INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010",
}